Skip to main content

More about Medipee and our idea

Our mission

Learn more about Medipee's team and goals

Medipee is a pioneer in a new era of personal health consciousness and prevention.

We believe that regular, affordable and easy-to-perform urine monitoring helps people significantly improve personal well-being and detect diseases early.

Our platform system is a great way to inform people in a simple and intuitive way, enabling them to better understand their bodies. In many cases, this allows proactive action as long as there is still time for effective therapy.

According to the European Commission for Public Health
(EPHA), between 70% and 80% of overall health costs in the EU are spent on chronic diseases. This equates to €700 billion per year as the trend increases.

Globally, numbers are far more dramatic. The World Economic Forum (WEF) states that the global economic impact of the five major diseases (NCDs) – cardiovascular disease, chronic respiratory disease, cancer, diabetes and mental illness – could be around US$47 trillion by 2030.

By far the largest part of these diseases is relevant for prevention. This means that through good prophylaxis, diseases can partly be completely avoided or their severity alleviated. Medipee would like to make a contribution to at least reducing this proportion!

Learn more about Medipee's team and goals

Medipee is a pioneer in a new era of personal health consciousness and prevention.

Find out more

We believe that regular, affordable and easy-to-use tests help people to significantly improve their personal well-being and detect diseases at an early stage.

Our platform system is a great way to inform people in a simple and intuitive way, enabling them to better understand their bodies. In many cases, this allows proactive action as long as there is still time for effective therapy.

According to the European Commission for Public Health
(EPHA), between 70% and 80% of overall health costs in the EU are spent on chronic diseases. This equates to €700 billion per year as the trend increases.

Globally, numbers are far more dramatic. The World Economic Forum (WEF) states that the global economic impact of the five major diseases (NCDs) – cardiovascular disease, chronic respiratory disease, cancer, diabetes and mental illness – could be around US$47 trillion by 2030.

By far the largest part of these diseases is relevant for prevention. This means that through good prophylaxis, diseases can partly be completely avoided or their severity alleviated. Medipee would like to make a contribution to at least reducing this proportion!

Getting to know vision

The Management Team

Shaping future medicine together

Paul

Chief Technology Officer (CTO)

Frank

Managing Director (CEO)

Noel

Head of Marketing & Sales (CMO)

History

From the idea to the foundation

Medipee GmbH was founded in 2017 by Thomas Prokopp, Paul Bandi and Frank Willems. Medipee has set itself the goal of decisively improving people’s quality of life through simple and automated health care. The motivation for the development of our product was a disease discovered too late, which would have been diagnosed earlier by regular urine examination. During the research, we became aware that the average person goes to the toilet up to six times a day. But the health information contained in the urine quickly disappears into the toilet.

We see the solution to this problem in an automated urinalysis for the toilet, which can be carried out easily and without much to do by anyone. Best in a routine as simple and intuitive as daily tooth brushing.

To achieve this goal, our team combines expertise and years of experience in the fields of marketing, product development, engineering and medical technology.

Close Menu